id="post-2462" class="twentyseventeen-panel post-2462 page type-page status-publish hentry">

Upcoming Event

This is just a text.

Message

Dear Colleagues,

On behalf of the Organizing Committee of APASL STC Islamabad 2019, it is my great pleasure to welcome all the participants across the country and from abroad to attend the esteemed Conference on Viral Hepatitis from December 5-8, 2019 at Serena Hotel Islamabad, Pakistan. The theme of the meeting is Elimination of Viral Hepatitis by 2030 “From Dream to Reality”.

It is indeed an honor that PSSLD will be holding Third APASL Single Topic Conference this year. PSSLD is working with clear objective to create awareness among health care workers and to sensitize them to the burden of Liver diseases and its implications in the community.

The meeting’s content and activities are tailored to a wide audience of Hepatologists, Gastroenterologists, General practitioners and Postgraduate students. In this meeting we have included several interactive sessions with live audience response. Scientific program has CME credits and offers fantastic updates for consultants, trainees and primary care physicians. Faculty will include international key opinion leaders, mainly from the Asia Pacific region as well as from home.

We urge our colleagues to participate enthusiastically and honor us with their presence. This will be an exciting and educational meet for all.

All the committees are working very hard to make it a memorable event. It would be a great opportunity to meet and network with like-minded colleagues.

It will be winter in Islamabad which is surrounded by Margalla Hills and you will need warm clothing if you intend to move around. Remains of ancient civilization of Ghandara (Taxila) are just nearby (45 minutes’ drive) and if you wish to have a trip to snow covered mountains it is just 40 Km away.

Looking forward to welcome you all in the beautiful city of Islamabad.

Prof. Masood Siddiq
President PSSLD
Chair Organizing Committee

Event Schedule

Here is our event schedule

Image
Image

Highlights

Pre-Conference Workshop

Workshops for PG Trainees & Family Physicians

State of the Art Lectures

Scientific Symposia

Poster Presentation

Free Papers & Presentations

Exhibition

Social Program

Young Investigator Awards

Image

Program Summary

It is indeed an honor that PSSLD will be holding APASL Single Topic Conference this year. We are pleased and honored to inform our esteemed colleagues and participants that a four-day conference on “Elimination of Hepatitis from Dream to Reality” will be held on Dec 5-8, 2019.

Image

General Information

Language

The official language of the conference is English, simultaneous translation will not be provided.

Climate

In December temperature in Islamabad range from 2C – 24C.

Time Zone

The time zone in Pakistan is Greenwich Mean Time (GMT) + 5 hour.

Banking and Exchange

The Pakistan monetary system is Rupee. Foreign currency may be changed at banks during normal banking hours (09:00-16:00), or hotels, airports and in exchange offices. All major credit cards are acceptable in most hotels, restaurants and shops.

Liabilities & Insurance

The organizer is not able to take any responsibility whatsoever for injury or damage involving persons and property during the meeting. Participants are advised to take out their own personal travel and health insurance for their trip.

Official Letter of Invitation

A personal letter of invitation can be sent to the participants on request.

Visa Requirements

Participants are requested to check with the Pakistani embassy/consulate in their home country or with their travel agency for visa requirements. It is the responsibility of the participant to obtain a visa if required.

Food & Beverages

Business lunches and coffee/tea during breaks (as indicated in the program) are included in the registration fee.

National Airline

Pakistan International Airline is the national airline which operates in all major European, North American and Asian countries. Other airlines operating in Pakistan are: Emirates Airline, Gulf Airlines, Qatar Airlines, Etihad Airlines, British Airlines, Turkish Airlines, Royal Thai Airline Malaysian Airlines, Air China and Thai United.

Hotel Accommodation

Serena Hotel Islamabad: Khayaban-e-Suhrwardy, G-5, Islamabad.
Phone: (+92- 51) 2874000.
Website: www.serenahotels.com

Marriott Hotel Islamabad: Agha Khan Rd, F-5/1 Shalimar 5 Islamabad.
Phone: (+92- 51) 2826121
Website: www.marriott.com

Image

Event Speakers

  • DR. Rino Alvani Gani, SpPD KGEH

    Premier Bintaro Hospital Jl. MH Thamrin No. 1
    Sector 7 Bintaro Jaya
    Tangerang Selatan 15224 - Indonesia
    Specialty:
    • Internal Medicine
    • Consultant Gastro Hepatology
    Medical Qualifications / Experience:
    • Medical Staff of the Department of Internal Medicine RSCM / FKUI
    • Premier Bintaro Hospital
    Medical Education:
    • Faculty of Medicine, University of Indonesia, 1987
    • Internal Medicine Specialist Education FKUI, 1996
    • Gastroenterology-Hepatology Consultant FKUI-PAPDI, 2000
    • Medical Virology & Jichi Medical School, Japan, 1998
    Professional Memberships:
    • Member IDI
    • PAPDI Members
    • PPHI Secretary of PEGI
    • PGI Members
  • Fasiha Kanwal, M.D., MSHS

    Houston VA HSR&D Center for Innovations, Quality,
    Effectiveness, and Safety (Office)
    Texas 77021United States
    Positions:
    • Editor-in-Chief
      • Clinical Gastroenterology and Hepatology
    • Professor and Section Chief
      • Medicine
      • Gastroenterology
      • Baylor College of Medicine
      • Houston, Texas
    • Member
      • Dan L Duncan Comprehensive Cancer Center
      • Baylor College of Medicine
      • Houston, Texas, United States
    Qualifications:
    • M.S.H.S from UCLA School Of Public Health, United States, 2004
    • M.D. from King Edward Medical College, Pakistan, 1995
    Certifications:
    • Missouri Medical License
    • National Board of Medical Examiners
    • American Board of Internal Medicine
    • ABIM Gastroenterology Certification
    • ABIM Transplant Hepatology Certification
    Honors & Awards:
    • Editor-in-Chief>
    • Annual meeting distinguished poster
    • Emerging Leaders in Gastroenterology Award
    • Plenary session at the VA National HSR&D Meeting
    • Research Excellence in GI and Liver (REGAL) Award
    Professional Interests:
    • Process and outcomes of care in patients with chronic liver diseases
    • Quality management in liver disease
    • Medical decision-making
    • Patient reported outcomes (health related quality of life)
    • Cost effectiveness analyses
    • Cirrhosis and related complications
    Learnmore
  • LAI WEI, MD

    Premier Bintaro Hospital Jl. MH Thamrin No. 1
    Sector 7 Bintaro Jaya
    Tangerang Selatan 15224 - Indonesia
    Personal Profile:

    Lai Wei is a Professor of Hepatology & Medicine, and is the Director of Peking University Hepatology Institute since 2004 and Chief of Department of Hepatology at Peking University People’s Hospital since 2001. His current research interests involve antiviral treatment of hepatitis B and C. Dr. Wei is the President of the Chinese Society of Hepatology. He served to develop the Chinese Guideline for Management of Hepatitis B, and Management, Diagnosis and Prevention of Hepatitis C virus Infection. In addition, Dr Wei is involved in Kidney Disease Improving Global Outcome to develop a Guideline for HCV Infection, Diagnosis, Prevention and Management in Kidney Disease and contributes to APASL for hepatitis C guideline.

  • Tehami, Dr Nadeem A

    BSc, MRCP (UK), MRCP Gastroenterology,
    FEBGH, FRCP (Glasg)
    Specialty:
    • Gastroenterology
    Sub-specialty:
    • Hepatology (liver) and hepatobiliary (gallbladder and bile ducts) medicine
    Training & Education
    • Undergraduate education/training - Quaid-e-Azam University, Army Medical College, Pakistan (2002)
    • General medical SHO rotation - London South Thames rotation (2004-07)
    • Gastroenterology/hepatology training in various institutions in London, Glasgow and Birmingham between 2007 and 2014 including West Midlands gastroenterology/hepatology rotation
    • Transplant hepatology module - University Hospital of Birmingham (2012-13)
    • HPB endoscopy fellowship - Heart of England NHS Foundation Trust (2013-14)
    Experience:

    Dr Tehami is a consultant gastroenterologist who specialises in hepatology and hepatobiliary medicine. He joined UHS in August 2018. He previously worked as a consultant hepatologist at Shrewsbury and Telford Hospitals NHS Trust for over three years before joining UHS.

    He looks after patients with a wide range of hepatopancreaticobiliary (HPC) problems, but has a specialist interest in HPB endoscopy (ERCP/EUS). His clinical role is divided into inpatient ward work, outpatient clinics and endoscopy lists.

    Dr Tehami's main clinical interests are HPB medicine and endoscopy, endoscopy teaching and training, and improving patient care through education of other health professionals and service development.

    Current roles:
    • MRCP PACES examiner
    • Member of the MRCP part 1/2 question writing group
    • Advance life support instructor (Resus Council UK certified)
    • JAG accredited endoscopy trainer
    • Part of the faculty on PACES and endoscopy training courses overseas
    • Reviewer for Journal of Medical Sciences KMC
    Key Achievements:
    • Dr Tehami cofounded an organisation called PAGHE and initiated the overseas doctors development programme. Under this banner a national conference was arranged for junior doctors which was attended by over 100 delegates. The purpose was to support and guide international medical graduates for the best patient care in the NHS.
    • Dr Tehami has conducted several interview courses overseas for prospective RCP MTI (Medical Training Initiative) programme applicants as an effort to support NHS recruitment.
    • Dr Tehami has an active interest in telemedicine and FOAMed. He has produced several eductional videos for patients and endoscopy nurses.
    Research:

    Below is a selection of Dr Tehami's most recent publications:

    • Non-selective β-blockers are associated with improved survival in patients with ascites listed for liver transplantation. Gut. 2015 Jul 1;64(7):1111-9.
    • Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease. QJM: An International Journal of Medicine. 2017 Feb 1;110(2):73-81.
    • Isolated unilateral tongue oedema: the adverse effect of angiotensin converting enzyme inhibitors. Current drug safety. 2012 Nov 1;7(5):382-3.
    • Extrahepatic manifestations of hepatitis C. Frontline gastroenterology. 2013 Nov 4:flgastro-2013.
    • Probiotics' Effects on Perception of Health and Bowel Frequency: A Double Blind Randomized Placebo Controlled Clinical Trial. Gastroenterology. 2017 Apr 1;152(5):S819.
  • Norah Terrault, MD

    Professor Emeritus, Medicine
    513 Parnassus Ave, MSB
    San Francisco, CA 94117
    Education and Training:
    • University of California, San Francisco Post-Doc Fellow/Scholar, Medicine, 1995
    • University of California, San Francisco, Clinical Fellowship, Gastroenterology
    • University of California, San Francisco, Residency
    • University of Alberta, M.D., School of Medicine, 1987
    Research Activities and Funding:
    • Bay Area Hepatitis C Cooperative Research Center
      Role: Co-Investigator (Jun 15, 2010 - May 31, 2015)
    • Hepatitis B Research Network (HBRN): Natural History and Treatment Studies
      Role: Principal Investigator (Sep 30, 2008 - May 31, 2020)
    • Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)
      Role: Principal Investigator (Jun 15, 2002 - Jun 30, 2020)
    • Resistance to Antiviral Therapy in Chronic Hepatitis C
      Role: Principal Investigator (Aug 1, 2001 - Apr 30, 2007)
    Learnmore
  • Wan-long Chuang

    Vice Superintendent, Kaohsiung Medical University Hospital
    Professor Department of Medicine, Kaohsiung Medical University
    Education:
    • M.D, School of Medicine, Kaohsiung Medical University
    • MS, Postgraduate Institute, Kaohsiung Medical University, Taiwan
    • PhD, Postgraduate Institute, Kaohsiung Medical University, Taiwan
    Experience:
    • Lecturer, Department of Medicine, Kaohsiung Medical University
    • Associate Professor, Department of Medicine, Kaohsiung Medical University
    • Director, Faculty of Medicine, School of Medicine, Kaohsiung Medical University
    • Chief, Hepatobiliary Division, Department of Internal Medicine
    • Chief, Department of Preventive Medicine
    • Director, Ultrasound Center
    License:
    • Specialist of Taiwan Society of Internal Medicine
    • Specialist of the Gastroenterology Society of Taiwan
    • Specialist of Taiwan society of Ultrasound in Medicine
    Professional Specialty:
    • Hepatobiliary and Pancreatic Disease
    • Abdominal Ultrasound Examination
    • Hepatitis Treatment
  • XIAOYUAN XU, PHD

    China
    Personal Profile:

    Professor Xiaoyuan Xu graduated from thre First Hospital of Lanzhou Medical College in 1988. He is currently a chief of the institue of infectious disease,Peking University.Professor Xu is also a vice chief of the Department of Infectious Disease,Peking Unicersity First Hospital.

    Professor Xu is a standing committee member of the Liver Disease Association of China; a vice chairman of the Liver Disease Association of Beijing,China;a vice leader of the Group of AIDS,Infectious Disease Association of China;a membership of Chinesee Medical Association.Profeesor Xu is editor of National Medical Jornal of China;Chinese Journal of Hepatology;Clinical Internal Medicine Journal of China and World Chinese Journal of Digestology.Professor Xu has published 80 papers about HIV/AIDS/HBV/HCV/SARS.

  • ZHONGPING DUAN, MD, PHD

    President of Chinese Society of Hepatology
    Chinese Medical Association
    Personal Profile:

    Prof. Duan is the Vice President of Beijing Youan Hospital Capital Medical University and President of Chinese Society of Hepatology, Chinese Medical Association. He is also the director of Translational Hepatology Institute of Capital Medical University and Director of Liver Division of Wu Jieping Medical Foundation. He is a Co-chief Editor of Journal of Clinical Hepatology and Chinese Journal of Gastroenterology and Hepatology. He has been the Chairman of Chinese Severe Liver Diseases Meeting (2007-2018).

    Prof. Duan has been awarded Beijing Science and Technology Progress Prize, Chinese Medical Science and Technology Prize, Wu Jieping Prize for Medical Innovation; Science and Technology Progress Prize of Hebei Province and National Prize for Progress in Science and Technology.

  • Jidong Jia

    Professor of Medicine & Director,
    Liver Research Center, Beijing Friendship Hospital,
    Capital Medical University, China
    Personal Profile:

    He received his doctor;s degree from Capital Medical University, Beijing China and finished his postdoctorial training at Klinikum Benjamin Franklin, Free University of Berlin, Germany. His clinical interests include the chronic viral hepatitis, autoimmune and cholestatic liver diseases. His main research work includes the pathogenesis and treatment of l liver fibrosis.

    He is the President-Elect of IAS, Past President of APASL (2009-2010) and Immediate Past President of the Chinese Society of Hepatology. He currently serves China Foundation of Viral Hepatitis Prevention and Control as vice president, and CEVHAP as Executive Council Member. He also serves as associate editor for Journal of Gastroenterology & Hepatology and Hepatology International.

  • Professor Dr. A. Kadir Dökmeci

    Ilgaz / Çankiri Turkey
    Education:
    • 1954-1965 Primary and High School Ankara
    • 1965-1971 Ankara University Faculty of Medicine
    • 1971-1976 Assistant, Department of Internal Medicine, AÜTF
    • 1976-1978 Assistant, Department of Gastroenterology, AÜTF
    • 1978-1979 Chief Assistant, Department of Gastroenterology
    • 1979-1979 Japanese Course, Osaka, Japan, (6 Months)
    • 1979-1981 Study, training and research, 1st Internal Medicine Clinic of Chiba University School of Medicine
    • 1981-1981 Visiting Researcher, Goethe University Medical School Gastroenterology Clinic (1 Month)
    • 1981-1981 Observer Specialist, Northwestern University School of Medicine.Chicago, (20 Days) USA
    • 1981-1982 Gastroenterology Specialist, AÜTF
    • 1982-1988 Associate Professor, Department of Gastroenterology, AÜTF
    • 1988 Appointment as Professor, Department of Gastroenterology, AÜTF
    • 1988-1989 Visiting Professor .Chiba University. Chiba, Japan
    • 1989 ERCP Course. Middlesex Hospital. London, England
    • 1989-1994 Professor, Department of Gastroenterology, AÜTF
    • 1994-1997 Presidency of Internal Medicine, AÜTF
    • 1997-2000 Department of Gastroenterology, AÜTF
    • 2002-2003 Visiting Professor, Department of Gastroenterology, University of California, Irvine, Los Angeles, USA
    • 2003 Professor, Gastroenterology, AÜTF
    Award:
    • INOHANA Award Contribution to Turkish-Japanese cooperation in the field of Gastroenterology
    Education:
    • Ankara University Medical School, Turkey
    • Chiba University School of Medicine, Japan
    • Gethoe University, Frankfurt, Germany
    • University of Calfornia, Irvine, USA
    Diplomas:
    • Medical Diploma
    • Internal diseases
    • Gastroenterology
    Memberships:
    • 1973 Turkish Gastroenterology Association
    • 1994-1998 Member of the Board
    • 1984 International Association for the Study of the Liver (IASL)
    • 1985 Turkish Ultrasonography Association
    • 1988 Japanese Society of Gastroenterology
    • 1990 Gastrointestinal Endoscopy Association
    • 1990-1998 Member of the Board
    • 1991 Turkish-Japanese University Association
    • 1991-1995 Member of the Board
    • 1991-1994 Member of the Regulatory Commission for Gastroenterology Drugs of the Ministry of Health
    • 1992 Turkey's Liver Research Association
    • 1994-2000 Presidency of Gastroenterology Drugs Regulatory Commission of Ministry of Health
    • 1996 Turkish Society of Surgical Hepato-Pancreato-Bilier Diseases
    • 1996 Turkish-Japanese Foundation
    • 2002 Hepato-Bilio-Pancreatology Association (HEBIPA) President
    • 2003 International Society of Gastroenterology and Surgery
  • Prof. Gregory Dore

    Professor and Program Head
    Viral Hepatitis Clinical Research Program, Sydney
    Personal Profile:

    Professor Dore is Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Sydney, and Infectious Diseases Physician, St Vincent’s Hospital, Sydney, Australia. He has been involved in viral hepatitis and HIV epidemiological and clinical research, clinical care and public health policy for 20 years. He has developed extensive national and international collaborations, and is internationally recognized in the areas of HCV natural history and epidemiology, therapeutic strategies for acute and chronic HCV infection, particularly among people who inject drugs, and HCV elimination strategies.

    Professor Dore established the St Vincent’s Hospital viral hepatitis service in 1999, and has led its development into one of the leading national and international hepatitis C treatment services, with a particular focus on marginalised populations including people who inject drugs and homeless persons.

    Qualifications:
    • 2001 PhD, University of New South Wales
    • 1997 MPH, University of Sydney
    • 1995 FRACP, Royal Australasian College of Physicians
    • 1987 BSc, University of New South Wales
    • 1987 MBBS, University of New South Wales
    Grants:

    Major Category 1 Grants

    • NHMRC: Practitioner Fellowships (2012-2016: $523K; renewed for 2017-2021: $569K).
    • NHMRC Program Grant as CI (2014-2018: Hepatitis C infection: epidemiology, pathogenesis, and treatment; $5,428K, $1,307K to Dore)
    • NHMRC Partnership Grants as CI (2014-2019: Surveillance and Treatment of Prisoners with hepatitis C (SToP-C), $1,495K; 2016-2020: Enhancing hepatitis C virus among injecting drug users in the opiate pharmacotherapy setting, $1,490K).
    • NIH R01 Grants as CI (2015-2020: A randomised study of interferon-free treatment for recently acquired hepatitis C in people who inject drugs and people with HIV coinfection (REACT study), $US 3,700K; 2011-2016: International Collaborative of prospective studies of HIV and Hepatitis in IDU, $2,289K).
    Award:
    • 2007, 2012, 2017 NHMRC Practitioner Fellowship
    • 2007 Frank Fenner ASID Award for Advanced Research in Infectious Diseases
    • 2016 Fellow of Australian Academy of Health and Medical Science
  • Prof. Jinlin Hou

    Director and Professor of
    The Hepatology Unit
    &
    Department of Infectious Diseases
    Personal Profile:

    Professor Jinlin Hou is the Director and Professor of the Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China. Professor Hou is the president of APASL 2017 and the president of Chinese Medical Association of Infectious Diseases(2013-2016. Professor Hou joined the University Department of Medicine of Nanfang Hospital in July 1984. Between 1993 and 1994,he received training in the Department of Medicine at St. Mary’s Hospital Medical School in London, UK. Between 2000 and 2001, Professor Hou was a visiting Fellow at the Institute of Hepatology, London, UK. He has been invited to deliver talks at both national and international liver conferences owing to his expertise in viral hepatitis and other liver diseases. His current research interests include the clinical management of liver and Infectious Diseases and the molecular virology and immunology of hepatitis virus infection. He has published more than 500 articles in both national and international journals, including GUT, Hepatology, Journal of Immunology,Journal of Hepatology, Science,LANCET Infect Dis, NEJM et al.

  • NECATİ Örmeci

    Departments of Medical Sciences
    Personal Profile:

    I was born in 1952 in the Senirkent district of Isparta. I finished primary and secondary school here. In 1976, I graduated from Ankara University Faculty of Medicine. About a week after my graduation, I became an assistant in the Department of Internal Medicine at the same faculty. Between 1983-85, I specialized in Gastroenterology and in 1985 I became an assistant professor in Ankara University Faculty of Medicine, Department of Gastroenterology. I went to Japan in 1985 and studied at Tokyo Women's Medical Collage on diagnostic endoscopy, endoscopic ultrasonography and endoscopic interventions. I returned from Japan at the end of 1986. I became an associate professor in 1988. In 1990, with a scholarship from TUBITAK, I also worked in Tokyo National Cancer Center for 4 months on endoscopy, cytology and histepatology of early gastric cancer. I became a professor in 1994. In 1999, I worked for a month at the Cleveland Clinic in Miami to improve my knowledge and experience. I am still working in Ankara University Faculty of Medicine Department of Gastroenterology. In September 2006, I was elected as the Head of the Internal Medicine Department of our faculty.

  • Bilal Hameed, MD

    Associate Professor, Hepatologist
    Personal Profile:

    Dr. Bilal Hameed is specialist who cares for patients with liver disease. His expertise includes providing care before and after liver transplantation.

    Hameed earned his medical degree at Dow University of Health Sciences in Pakistan and completed an internal medicine residency at the University of Minnesota. He completed a fellowship in gastroenterology at the University of Minnesota and a fellowship in transplant hepatology at UCSF.

    In addition to authoring numerous peer-reviewed articles, Hameed has received many awards and honors in his field. He is a member of the American Association for the Study of Liver Diseases, American Gastroenterological Association and American Society of Transplantation.

    Board Certification:
    • Transplant Hepatology, Amer Bd of Internal Medicine/Transplant Hepatology
    • Gastroenterology, American Board of Internal Med/Gastroenterology
    Education:
    • Dow School of Medicine 2000
    Residencies:
    • University of Minnesota, Internal Medicine 2006
    Fellowships:
    • University of Minnesota, Gastroenterology 2009
    • UCSF Medical Center, Transplant Hepatology 2010
    Selected Research and Publications:
    1. Kim D, Cholankeril G, Li AA, Kim W, Tighe SP, Hameed B, Kwo PY, Harrison SA, Younossi ZM, Ahmed A. Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014. Liver Int. 2019 May 13.
    2. Leventhal TM, Gottfried M, Olson JC, Subramanian RM, Hameed B, Lee WM. Acetaminophen is Undetectable in Plasma From More Than Half of Patients Believed to Have Acute Liver Failure Due to Overdose. Clin Gastroenterol Hepatol. 2019 Feb 05.
    3. Trauner M, Gulamhusein A, Hameed B, Caldwell S, Shiffman ML, Landis C, Eksteen B, Agarwal K, Muir A, Rushbrook S, Lu X, Xu J, Chuang JC, Billin AN, Li G, Chung C, Subramanian GM, Myers RP, Bowlus CL, Kowdley KV. The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis. Hepatology. 2019 Jan 19.
  • Professor Salimur Rahman

    Professor of Hepatology Bangabandhu Sheikh Mujib
    Medical University Shahbagh,
    Dhaka-1000, Bangladesh.
    Personal Profile:

    Professor Salimur Rahman is a veteran Hepatologist of Bangladesh and at present working as professor of hepatology Bangabandhu Sheikh Mujib Medical University which is the only medical university of this country. He is one of the founders of the discipline in this country. He is a co-editor of 1) ‘Liver: A Complete Book on HepatoPancreato-Biliary Diseases’ and 2) ‘Comprehensive Text Book of Hepatitis B’ published by Elsevier and Jaypee respectively. Professor Rahman has over 100 publications in international and regional journals. He is Editor-in-Chief of Euroasian Journal of Hepato-Gastroenterolgy, the official publication of Euroasian Gastroenterological Association and Viral Hepatitis Foundation Bangladesh. He is the current President of Association for the Study of the Liver, Dhaka, Bangladesh – the national association of Hepatologists of the country and the Senior VicePresident of Association of Physicians of Bangladesh – the premier platform of specialist physicians of Bangladesh. He is also the founder Chairman of Viral Hepatitis Foundation Bangladesh. He served as member national committee for Hepatitis B virus in Bangladesh and presently serving as executive committee member of Asian Pacific Association for the study of the Liver (APASL). He is the current president of South Asian Association for the Study of Liver (SAASL). Professor Salimur Rahman is a leading interventionist of Bangladesh and has pioneered the transformation of Hepatology from a theoretical to an interventional super-specialty in this country. He is a senior faculty member of the Department of Hepatology, Bangabandhu Sheikh Mujib Medical University. He is a Fellow of Bangladesh College of Physicians and Surgeons, Royal College of Physicians of Edinburgh and Royal College of Physicians of Dublin.

Image

Organizing Committee

Patron

Prof. Wasim Jafri

President & Chair Organizing Committee

Prof. Masood Siddiq

Steering Committee
  • Prof. Wasim Jafri
  • Prof. Saeed Hamid
  • Prof. Masood Siddiq
  • Prof. Zaigham Abbas
Organizing Committee
  • Prof. A.A Durrani
  • Prof. Muzzafar Latif Gill
  • Prof. Javaid Aslam Butt
  • Prof. Tassawar Hussain
  • Prof. Shoaib Shafi
  • Prof. Faisal Saud Dar
  • Prof. Ghias-un-Nabi Tayyab
  • Dr. Mashood Ali Khan
  • Dr. Adil Naseer
  • Dr. Arshad Abbasi
  • Dr. Altaf Baqir Naqvi
  • Prof. Wazir Sheikh
  • Prof. Bashir Sheikh
Scientific Committee
  • Prof. Amjad Salamat (Chair)
  • Dr. Muhammad Salih (Co-Chair)
  • Dr. Najam ul Hassan Shah
  • Prof. Farrukh Saeed
  • Dr. Muhammad Naseet
  • Prof. Zafar Ali
  • Dr. Lubna Kamani

Abstract Form Submission

SINGLE TOPIC CONFERENCE - 2019

Abstract should be developed according to following format and should not be of more than 250 words. Last date for Abstract Submission is October 31, 2019

Click here for Offline Submission

Message Us

Font Resize
DAY 1: Thursday, 05 Dec 2019
Time: 0900-1115 hrs.
Venue: Marriot Islamabad
Director: Yasir Waheed
Session-I: Post Graduates Day: Research Workshop
Time Faculty Name Topic
0900-0905 Masood Siddiq Welcome Message
0905-0930 Wasim Jafri Balancing Novelty with Feasibility in Research Design (You can pick up your own talk/title)
0930-1000 Amna Subhan Butt How to Write a Good Research Paper
1000-1030 Dilshad Data Management & Analysis
1030-1115 Fasiha Kanwal Meta-Analysis
1115-1130 Tea Break
DAY 1: Thursday, 05 Dec 2019
Time: 1130-1330 hrs.
Venue: Marriot Islamabad
Director: Yasir Waheed
Session-II: Post Graduates Day: Research Workshop
Time Faculty Name Topic
1130-1200 Zaigham Abbas The Do’s and Don’ts of Persuasive Grant Writing (You can pick up your own talk/title)
1200-1230 Saeed Sadiq Hamid Ethics & Integrity in Research
1230-1300 Fasiha Kanwal How to Publish in High Quality Scientific Journals
1300-1330 Yasir Waheed How to Improve Research Paper before Submission into Journal and Pre-submission Checklist
1330 Lunch / Registration Serena and Back
DAY 1: Thursday, 05 Dec 2019
Time: 1600–1930 hrs.
Venue: Marriot Islamabad
Director Mohammed Salih
Asst-Director Dr. Yasir Abbas
Session-III: Post Graduates Day case based PG workshop
Time Session Speaker Supervisor Moderator Topic Chair persons
1600-1620 Case-1 Jehanzeb Afridi Masood Siddiq Refractory Ascites 02 x International Faculty
1620-1640 Case-2 Adil Naseer Acute on Chronic recurrent Encephalopathy
1640-1700 Case-3 Farrukh Saeed Variceal Bleed Management after Endoscopy failure
1700-1710 Wrap up by chairs
1710-1730 Case-4 Amna Subhan Butt Altaf Alam Sepsis induced ACLF 02 x International Faculty
1730-1750 Case-5 Zahid Azam HBV induced ALF
1750-1810 Case-6 Dr. Hyder Wajid Abbasi Mashhood Ali Khan DILI (Anti TB Drugs induced)
1810-1820 Wrap up by chairs
1820-1840 Case-7 Akif Dilshad Muhammad Salih Pre-transplant Assessment and Transplant in CLD because of NASH 02 x International Faculty
1840-1900 Case-8 Zaigham Abbas PBC case scenario
1900-1920 Case-9 Shahid Rasool Resistant to Steroids
1920-1930 Wrap up by chairs
2000 Dinner

This session will be case based presentations by PG GI trainees; it will be 10 min presentation and 10 min discussion

DAY 2: Friday, 06 Dec 2019
Time: 0900-1040 hrs.
Venue: Serena Islamabad
Session-I: Public Health Seminar
Chairs: Zhongping Duan, Wasim Jafri
Moderator: Arsalan Shahzad
Time Topic Speakers
0900-0910 Opening and WELCOME Masood Siddiq
0910-0925 Who is Spreading Hepatitis What are we doing about it? Faisal Wasim Ismail
0925-0940 Role of Transfusion Services in Prevention of Hepatitis Nuzhat Salamat
0940-0955 Decentralizing the HCV Health Care Delivery to Primary Care - is it time? Ghias un Nabi Tayyab
0955-1010 Good and Simplified Service Delivery for HCV Care in a Resource Limited Country Imam Waked
1010-1025 Key challenges for HCV Elimination in Public Health Domain Fasiha Kanwal
1025-1040 Effective Policy for HCV Elimination, Ways and Means Ministry of Health (Masood)
1040-1055 Tea break
DAY 2: Friday, 06 Dec 2019
Time: 1055-1300 hrs.
Venue: Serena Islamabad
Session-II: Public Health Seminar
Chairs: Javaid Aslam Butt, Tassawar Hussain, Col Saad Rao
Time Topic Speakers
1100-1110 Is Prevention on Back Burner in the Era of DAAs? Saeed Sadiq Hamid
1115-1130 Progress in Elimination of Hepatitis What do the Numbers Tell us? Hassan Mahmood
1130-1145 Role of Innovation in Technology and delivery approach for Elimination of Viral Hepatitis Norah Terrault
1145-1200 HCV Elimination, Lessons from Egypt Imam Wakeed
1200-1215 Q&A – Discussion
1215-1230 HCV Elimination in Pakistan Huma Qureshi
1230-1245 Changing the Behavior Public and Personal does it Matter? Mowadat Hussain Rana
1245-1300 Media Partnership for HCV and HBV Elimination Wasif Nagi – Geo Group
1300-1400 Lunch & Prayer
DAY 2: Friday, 06 Dec 2019
Time: 1400-1530 hrs.
Venue: Serena Islamabad
Session-III: Public Health Seminar
Chairs: Ejaz Mohammad Khan, Qazi Masroor Ali, Javed Afridi
Time Topic Speakers
1400-1415 Role of Professional Bodies In HCV Elimination, Is Some Body Listening? Wasim Jafri
1415-1430 Drug Regulation Policies and Hepatitis Elimination DRAP C/O Huma
1430-1445 Politics of Advocacy for Hepatitis Elimination, Who should own it?
1445-1500 Q&A - Discussion
1500-1530 Patients Perspective Khalid Mahmood Gondal + Ali Noor
DAY 2: Friday, 06 Dec 2019
Time: 1600-1700 hrs.
Venue: Serena Islamabad
Session-IV: Inaugural Session
1530-1545 Guests to be seated
1600-1605 Tilawat from The Holy Quran
1605-1610 National Anthem
1610-1615 Welcome Address by The President PSSLD & Chair Organizing Committee Masood Siddiq
1615-1620 Address by the Chair Scientific Committee Amjad Salamat
1620-1625 Address by the Representative of Chinese Delegates ???
1625-1630 Address by the Patron PSSLD Waseem Jafri
1630-1635 Presentation of Memento to the Chief Guest
1635-1700 Address by the Chief Guest
1700-1715 Tea Break
DAY 2: Friday, 06 Dec 2019
Time: 1715-1830 hrs.
Venue: Serena Islamabad
Session-V: Public Health Seminar
Chairs: Noor Mohammad, Bakht Biland, Kamran Hassan
1715-1730 Progress on Hepatitis Awareness, Prevention and Treatment in Punjab Khalid Mahmood
1730-1745 Progress on Hepatitis Awareness, Prevention and Treatment in Sindh Zulfiqar Dharejo
1745-1800 Progress on Hepatitis Awareness, Prevention and Treatment in KPK Jamal Nasir
1800-1815 Progress on Hepatitis Awareness, Prevention and Treatment in Baluchistan Ismail Mirwani
1815-1820 Change Over
DAY 2: Friday, 06 Dec 2019
Time: 1830-2030 hrs.
Venue: Serena Islamabad
Session-VI: Free Papers
Chairs: Asim Anwar, Junaid Saleem, Zahid Azam
1820-2000 Free papers
2030 Dinner
DAY 3: Saturday, 07 Dec 2019
Time: 0900-0945 hrs.
Venue: Serena Islamabad
Session-I: Diagnostics in Hepatitis
Chairs: Shoaib Shafi, H.M. Ashraf, Khalid Mahmood
Time Topic Speakers
0900-0915 Point of Care Testing in HCV Saeed Sadiq Hamid
0915-0930 Noninvasive Serological Markers of Fibrosis in Chronic Hepatitis Rino A Gani
0930-0945 Imaging in Chronic Liver Disease Ehsan Kiyani
0945-0950 Q&A
DAY 3: Saturday, 07 Dec 2019
Time: 0955-1130 hrs.
Venue: Serena Islamabad
Session-II: Hepatitis B & Delta Symposium I
Chairs: Shuang Liu, Muzaffar Latif Gill, Yasir Waheed
Time Topic Speakers
0955-1010 HBV Viral Quasi-species and its Clinical Significance Li Chen
1010-1025 Machine Learning-assisted Viral Quasispecies analysis: a novel noninvasive approach for better appraising the Immune Tolerant phase of Chronic Hepatitis B virus infection Xinxin Zhang
1025-1040 Nucleoside Analogues Combined with TCM Anti-Fibrosis Ameliorate Prognosis of Chronic Hepatitis B Yuemin Nan
1040-1045 Q&A
1045-1115 State of the Art lecture:
Life Cycle of HDV – Biological and Therapeutic Implications
Mario Rizetto
1115-1130 Tea Break
DAY 3: Saturday, 07 Dec 2019
Time: 1130-1310 hrs.
Venue: Serena Islamabad
Session-III: Hepatitis B Symposium II
Moderator: Faisal Wasim Ismail
Chair: Saeed Sadiq Hamid
1130-1145 Mother to child transmission, HBV Management in Pregnancy Altaf Alam
1145-1200 Management of HBV Cirrhotics with and without Co-infection Sadik Memon
1200-1215 Chronic Hepatitis-B Treatment Options and Goals Wasim Jafri
1215-1230 HDV Management in 2019 and beyond? Mario Rizetto
1230-1240 Q&A
1240-1310 State of the Art lecture:
HBV from Functional to Complete Cure, Do East & West Differ in their Approach?
Norah Terrault
1310-1410 Lunch & Prayer
DAY 3: Saturday, 07 Dec 2019
Time: 1410-1600 hrs.
Venue: Serena Islamabad
Session-III: HCV
Chair: Israr-ul-Haq Toor, Farrukh Saeed, Shamail Zafar
Time Topic Speaker
1410-1425 HCV Treatment Naïve in 2019 Ghias un Nabi Tayyab
1425-1440 Treatment Failure in Era of DAAs Zaigham Abbas
1440-1455 Detection of Residual HCV-RNA in Patients who have Achieved SVR is Associated with Persistent Histological Abnormality Jinmin Zhao
1455-1510 Management of HCV in Decompensated CLD Bilal Hameed
1510-1525 Post Liver Transplant HCV Treatment Norah Terrault
1525-1530 Q&A
1530-1600 State of the Art lecture:
Management Landscape in Asia: Clinical Reality
Wasim Jafri
1600-1610 Break / Change Over
DAY 3: Saturday, 07 Dec 2019
Time: 1610-1710 hrs.
Venue: Serena Islamabad
Session-IV: Care of Cirrhotics Clinical Hepatology
Chair: Arif Nadeem, Bakht Biland, Noor Muhammad
Time Topic Speaker
1610-1625 Diagnosis of Cirrhosis Staging and Clinical Significance Muzaffar Latif Gill
1625-1640 Management of Ascites in Cirrhotics Amjad Salamat
1640-1655 Role of Albumin in Cirrhotics Beyond Plasma Expansion Nadeem Tehami
1655-1710 Variceal Bleed, New Developments Building on Old Knowledge Necati Ormeci
1710-1725 Tea Break
DAY 3: Saturday, 07 Dec 2019
Time: 1715-1800 hrs.
Venue: Serena Islamabad
Session-V: Cirrhosis - Potpouri
Chair: Altaf Baqir Naqvi, Sadiq Achakzai, Waseem Sarwar Malghani
Time Topic Speaker
1725-1740 Hepatic Encephalopathy - Practical Approach. Israr Toor
1740-1755 Optimal and Effective use of Medications in Cirrhotics Bilal Hameed
1755-1810 Multi detector CT for Hepatic Fibrosis, parameters and accuracy Aman Nawaz Khan
1810-1825 Pain Management in Cirrhotics Saleem ur Rehman
1825-1840 Algorithms in Care of Cirrhosis vs Traditional Approach or Combination - Pros and Cons Fasiha Kanwal
1840-1845 Q&A
 
2000-2045 Dinner
2100 Cultural Evening
DAY 4: Sunday, 08 Dec 2019
Time: 0800-0915 hrs.
Venue: Serena Islamabad
Session-I: Free papers
Chair: Asim Anwar, Junaid Saleem, Zahid Azam
0800-0915 Free Paper Session
DAY 4: Sunday, 08 Dec 2019
Time: 0930-1100 hrs.
Venue: Serena Islamabad
Session-II: Hepatocellular Carcinoma
Chair: Shahid Rasool, Ehsan Kiyani, Shahzad Riaz
Time Topic Speaker
0930-0945 What should Pakistan do to have an Effective Surveillance for HCC Zahid Azam
0945-1000 HCC management who should do it and how? Rino A Gani
1000-1015 HCC treatment BCLS or modified model Najam Ul Hassan Shah
1015-1030 Loco regional Curative and Non-Curative Therapies for HCC Kadir Dockmeci
1030-1045 Out of criterion TACE for HCC Atif Rana
1045-1100 Out of Criterion LDLT for HCC Faisal Dar
1100-1120 Tea break
DAY 4: Sunday, 08 Dec 2019
Time: 1120-1205 hrs.
Venue: Serena Islamabad
Session-III: NASH
Chair: Habib Jadoon, Adil Naseer Khan, Arshad Abbasi
Time Topic Speaker
1120-1135 Pathophysiology of NASH Mohammad Salih
1135-1150 Diagnosis and Management of NAFLD Jiangao Fan
1150-1205 Future Therapies for NASH Bilal Hameed
DAY 4: Sunday, 08 Dec 2019
Time: 1235-1405 hrs.
Venue: Different Halls
Session-IV: Case Based Workshops
Time Topic Target Audience Facilitators
1235-1405 Specific Liver Diseases of Pregnancy General Lubna Kamani, Amna Subhan Butt, Qazi Masroor Ali
1235-1405 NASH General Saeed Sadiq Hamid, Bilal Hameed, Mohammad Naseer
1235-1405 HCV Diagnosis and Treatment GPs/PGs Wasim Jafri, Faisal Wasim Ismail, Naeem Ullah
1235-1405 MDT for HCC PGs Najam ul Hassan Shah, Norah Terrault, Muhammad Salih
Concluding Ceremony 1410-1430 hrs.
Prize + Certificate Distribution
Lunch 1430-1500 hrs.